Redirect Notice

Looks like you clickedhttps://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd

If you do not want to visit that page, you can close this browser tab.